Skip to content

Difference in pain and functional outcome after arthroscopic debridement vs. debridement and biodegradable implanted balloon for irreparable rotator cuff tears.

Difference in pain and functional outcome after arthroscopic debridement vs. debridement and biodegradable implanted balloon for irreparable rotator cuff tears. - Debridement vs debridement and biodegradable balloon

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON50270
Enrollment
104
Registered
2016-10-21
Start date
2017-01-16
Completion date
Unknown
Last updated
2024-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

irreparable rupture of the muscles around the shoulder massive rotator cuff tears

Interventions

The patients will be randomized in a 1: 1 ratio in the two following sub-groups: Group 1: Subjects will undergo a surgical intervention: arthroscopic debridement and bicepstenotomie (when there was n

Sponsors

Reinier Haga Orthopedisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: -Subject has an irreparable supra- and infraspinatus tendon tear confirmed by ultrasound or MRI and is according to the Orthopaedic Surgeon a suitable candidate for debridement. -The symptoms of the subjects have been there for at least twelve months, despite conservative treatment, including physiotherapy, subacromial infiltration with corticosteroids or anti-inflammatory drugs. -Subjects are older than 18 years.

Exclusion criteria

Exclusion criteria: -Subject is not able to complete the daily questionnaires in Dutch. -Subject, in the opinion of the investigator, is not able to understand this investigation and is not willing and able to perform all study procedures and co-operate with investigational procedures. -Subject has glenohumeral osteo-arthrosis grade 3 and 4 (KELLGREN and LAWRENCE 494-502). -Subject has a total subscalpularis tendon tear. -Subject, in the opinion of the Investigator, is a drug or alcohol abuser (in the last 5 years) or has a psychological disorder that could affect their ability to complete subject reported questionnaires or be compliant with follow-up requirements -Subject was diagnosed and is taking prescription medications to treat a muscular disorder that limits mobility due to severe stiffness and pain such as fibromyalgia or polymyalgia. - Subject has an active elevation of less than 60 degrees (pseudoparalysis). -Subject has participated in a clinical investigation with an investigational product (drug or device) in the last three months. - Subject is allergic to the Balloon material -Subject has a medical condition with less than 3 years of life expectancy. .-Subject has refused voluntary, written informed consent to participate in this randomized controlled trial.

Design outcomes

Primary

MeasureTime frame
Pain measured through a Numeric Rating Scale (NRS).

Secondary

MeasureTime frame
-Time until the subjects receive a reversed shoulder prosthesis, if applicable - Functional outcome measured through Oxford Shoulder Score and Total Constant Score. - Radiological outcome measured through Ultrascound and X-ray -Complications

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)